Updated daily, Porzio Compliance Digest offers the latest information and eliminates the need for time-consuming research. Presented in a user-friendly interface, Porzio Compliance Digest is segmented into multiple databases that together address all areas of regulatory compliance.
This database includes current U.S. laws, regulations, and pending legislation relating to marketing practices, sales practices, and interactions with health care professionals. Topics include:
The database also includes medical school and healthcare institution interaction policies, industry codes of conduct, and industry guidance documents.
These databases include nationwide statutes, regulations, and pending legislation governing the distribution of trade products and samples by a company and its representatives. It details federal and state requirements on:
Includes databases for legend drugs, controlled substances, and prescription devices.
This database contains in-depth information on current global laws, industry codes, and pending legislation related to non-U.S. sales and marketing practices and interactions with health care professionals.
These databases present prescriptive and sampling authority for physicians and mid-level practitioners, including APRNs, physician assistants, midwives, dentists, podiatrists, veterinarians, optometrists and psychologists.
Includes databases for legend drugs and controlled substances.
This database contains searchable untitled and warning letters issued to life sciences companies by the FDA’s Office of Prescription Drug Promotion and CBER’s Advertising and Promotional Labeling Branch. It contains a section highlighting letters citing unlawful medical device promotion. The database contains copies of issued letters and associated materials, when available. Subscribers may search for specific letters and related violations, allowing them to assess trends in advertising and promotional labeling enforcement.
This database contains information on Established Inspection Reports related to Prescription Drug Marketing Act inspections, searchable by violation, inspector, and areas of inspection.
This database outlines federal government actions against life sciences companies that have allegedly violated, among other laws, anti-kickback laws, FDA regulations, and the False Claims Act. It includes corporate integrity agreement (CIA) summaries, searchable by CIA year, obligation, alleged violation, risk area, and product type.
Interested in learning more about how the team of experts at Porzio Life Sciences can help pharmaceutical, medical device and biotechnology organizations master the evolving regulatory environment? Please reach out with any questions.
We look forward to hearing from you.